DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Harden JL, Egilmez NK.
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
Immunol Invest 2012;
41 6–7 738-64
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.